leridistim
Term · Oncology and biomedicine · MLC-T-ONC-004786
A substance being studied for its ability to stimulate the production of blood cells during chemotherapy. It is a type of colony-stimulating factor. Also called SC-70935.
A recombinant chimeric dual G-CSF and IL-3 receptor agonist. Leridistim binds with high affinity to both the interleukin-3 (IL-3) and granulocyte colony-stimulating factor (G-CSF) receptors, thereby stimulating the production and maturation of neutrophils, platelets, and lymphocytes after chemotherapy.
| Identifier | MLC-T-ONC-004786 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | MPO |
| Synonyms | SC-70935; Myelopoietin |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-004786",
"term": "leridistim",
"field": "Oncology and biomedicine",
"definitions": [
"A substance being studied for its ability to stimulate the production of blood cells during chemotherapy. It is a type of colony-stimulating factor. Also called SC-70935.",
"A recombinant chimeric dual G-CSF and IL-3 receptor agonist. Leridistim binds with high affinity to both the interleukin-3 (IL-3) and granulocyte colony-stimulating factor (G-CSF) receptors, thereby stimulating the production and maturation of neutrophils, platelets, and lymphocytes after chemotherapy."
],
"abbreviation": "MPO",
"synonyms": [
"SC-70935",
"Myelopoietin"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/leridistim/"
}
Record 10,024 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.